Acute coronary syndrome patient related renal artery stenosis
의약학 > 내과학
김재연 , 이세환 , 진동규 , 신원용 , 이승진 , 박상호
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 162(총1쪽)
42846474.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Introduction: Atherosclerotic renal artery stenosis (RAS) is associated not only with hypertension, ischemic nephropathy, and cardiac disease but also with a considerably increased cardiovascular mortality. Acute coronary syndrome (ACS) also carries a high risk for mortality, however, the correlation between angiograpically documented ACS and significant RAS has not been fully proven. Materials and Methods: We enrolled 476 patients that performed both coronary angiography (CAG) and renal arteriography between January, 2007 and June 2011. We analyzed renal arteriographic findings of ACS group (STEMI, NSTEMI, unstable angina) vs. non-ACS group. We defined significant RAS as ≥50% diameter stenosis. Results: 198 patents (41.5%) were included in ACS group (STEMI; n=60, NSTEMI; n=50, Unstable angina; n=88). The prevalence of significant RAS among total patients was 16.5% (n=79). Compared with non-ACS group (ACS group vs. non-ACS group), the significant renal artery stenosis (25.2%; n=50 vs. 10.4%; n=29, p<0.05) were more frequently found in ACS group. There was no additional procedure (renal areriography) related renal complication. Conclusion: In this study, when compared to patients with non-ACS, patients with ACS had more prevalence of significant RAS. The impact of this result to clinical outcomes has to be elucidated.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.